PM360

NOVEMBER 14, 2023

In March of this year the three largest insulin manufacturers announced a dramatic reduction in the price of many commonly prescribed insulins and a monthly out-of-pocket (OOP) cap of $35 that went into effect in May. retail pharmacies to access a 30-day supply of Lantus for only $35. for only $35. References: 1.

Retail 52

Retail Pharmaceutical manufacturing Sales Insurance 52

Pharmaceutical Technology

SEPTEMBER 7, 2022

Pharmaceutical and healthcare companies are working continuously to improve patient adherence, which also impacts disease control and pharmaceutical industry revenues directly. Many companies use artificial intelligence (AI) to enable pharmaceutical manufacturers to overcome barriers to medication adherence.

Leads 52

Leads Pharmaceutical Patients Pharmaceutical manufacturing 52

World of DTC Marketing

AUGUST 12, 2022

The online retailer spends about $20 billion a year on R&D, despite being renowned for low prices and low profits. It also raises healthcare costs for public and private insurers alike. But of all the companies in the world, the one that invests the most in research and development is not a drug company. It’s Amazon.

Pharma 255

Pharma Retail Pharmaceutical manufacturing Pharmaceutical 255

Pharmaceutical Technology

SEPTEMBER 15, 2022

The growing demand from customers and pressures from global competitors have increased the significance of active pharmaceutical ingredients (API) chemical companies in the pharmaceutical industry supply chain.

Leads 52

Leads Marketing Pharmaceutical manufacturing Sales Management 52

European Pharmaceutical Review

NOVEMBER 8, 2022

For example, the US recently passed the Inflation Reduction Act, 1 which requires the Secretary of Health and Human Services (HHS) to negotiate prices for certain physician-administered and retail prescription drugs covered under Medicare Parts B and D.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

pharmaphorum

OCTOBER 26, 2022

The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We Previously he was with Accenture where he led large teams in outsourcing projects across Europe and US for clients in the transportation and retail businesses. Chiesi’s philosophy in action.

Patients 73

Patients Pharma Consulting Transportation 73

World of DTC Marketing

DECEMBER 10, 2020

The online retailer spends about $20 billion a year on R&D, despite being renowned for both low prices and low profits. Of all the companies in the world, the one that invests the most in research and development is not a drug company. It’s Amazon.

Insurance 181

Insurance Pharma Manufacturing Retail 181